Can Peak ATP and Adaptogens Support Energy Levels in Long COVID and ME/CFS?

When we hear the term "pre-workout," we typically picture high-stimulant powders designed to induce a massive adrenaline rush for heavy weightlifting. For someone living with Long COVID or ME/CFS, a traditional pre-workout supplement is often a recipe for disaster, as excessive stimulants can trigger tachycardia, exacerbate dysautonomia, and lead to a severe energy crash. However, Thorne's Pre-Workout Elite was formulated with a fundamentally different philosophy. Rather than relying on synthetic central nervous system overstimulation, it utilizes biologically identical cellular fuels and adaptogens to support the body's natural energy production pathways.

In the context of complex chronic illness, we must reframe how we view these ingredients. We are not looking at them as tools to achieve a personal record in the gym; rather, we are evaluating them as molecular support systems for activities of daily living. Whether the "workout" is a 10-minute stretching routine, a demanding cognitive task at work, or simply navigating a grocery store, the biological requirements for adenosine triphosphate (ATP), oxygen delivery, and neurotransmitter firing remain the same. By supplying the body with these foundational substrates, we may help lower the physiological cost of daily tasks.

This paradigm shift requires us to look deeply at the individual components of the formula. The ingredients in Pre-Workout Elite—specifically Peak ATP®, the PeakO2® mushroom blend, Alpha-GPC, and Guayusa extract—were selected for their ability to enhance systemic efficiency. They work synergistically to promote vasodilation, protect against oxidative stress, and facilitate efficient brain-to-muscle signaling. For a patient population struggling with microvascular dysfunction and neuroinflammation, these mechanisms offer a targeted approach to symptom management.

At the heart of cellular energy is adenosine 5'-triphosphate (ATP). In a healthy body, ATP is the primary intracellular "energy currency," continuously synthesized by the mitochondria through a process called oxidative phosphorylation. Every muscle contraction, nerve impulse, and biochemical reaction requires the cleavage of ATP into adenosine diphosphate (ADP), releasing the energy necessary for life. Peak ATP® is a patented, orally bioavailable form of ATP disodium. While historically it was believed that oral ATP degraded too quickly to be effective, modern pharmacokinetic research demonstrates that it acts systemically as a potent extracellular signaling molecule, binding to specific purinergic receptors on blood vessels to stimulate profound vasodilation and blood flow.

Alongside physical energy, cognitive function requires its own dedicated fuel sources. Alpha-GPC (L-alpha-glycerylphosphorylcholine) is a highly bioavailable, naturally occurring choline compound. Choline is an essential nutrient required for the structural integrity of cellular membranes and the synthesis of acetylcholine, a critical neurotransmitter. Acetylcholine is the primary chemical messenger responsible for memory formation, learning, sustained attention, and the signaling between nerves and muscles. Alpha-GPC easily crosses the blood-brain barrier, providing the central nervous system with the raw materials needed to maintain sharp cognitive processing and efficient neuromuscular communication.

The synergy between extracellular ATP and Alpha-GPC addresses both the physical and neurological demands of exertion. While ATP ensures that oxygen and nutrients are efficiently delivered to the peripheral tissues via enhanced blood flow, Alpha-GPC ensures that the brain can effectively coordinate these movements and maintain focus. In a healthy individual, these systems operate seamlessly in the background. However, when these pathways are disrupted by chronic illness, supplementing with these direct precursors can provide a crucial biochemical safety net.

To complement direct cellular fuels, the formula utilizes adaptogens—botanical compounds that help the body resist and adapt to physical, chemical, and biological stressors. PeakO2® is a clinically tested blend of six organic adaptogenic mushrooms, including Cordyceps militaris, Reishi, and Lion's Mane. Cordyceps, in particular, has a long history in traditional medicine for supporting respiratory function and combating fatigue. At a cellular level, the beta-glucans and antioxidants in this mushroom blend help improve oxygen kinetics, allowing the body to uptake and utilize oxygen more efficiently during physical exertion, thereby delaying the onset of muscular fatigue.

Finally, the formula addresses the need for alertness without the typical stimulant penalty through the inclusion of Guayusa extract. Guayusa (Ilex guayusa) is an Amazonian holly plant that naturally contains caffeine, but it delivers it within a unique phytochemical matrix. Unlike synthetic caffeine or coffee, which can trigger a massive release of epinephrine (adrenaline), Guayusa is rich in chlorogenic acids and L-theanine. These naturally occurring compounds modulate the absorption of caffeine and actively blunt the body's "fight or flight" stress response. The result is a sustained, smooth release of energy that supports alertness without inducing the jitters, anxiety, or dramatic crashes associated with standard energy supplements.

Together, these four pillars—Peak ATP, Alpha-GPC, PeakO2, and Guayusa—create a comprehensive support system. They do not force the body into an artificial state of overdrive. Instead, they optimize the physiological environment, improving blood flow, oxygen utilization, neurotransmitter availability, and stress resilience. For individuals navigating the delicate balance of chronic illness management, this nuanced approach to energy support is vastly superior to the brute-force stimulation of traditional pre-workout formulas.

To understand why cellular energy supplements are relevant to chronic illness, we must first examine how conditions like Long COVID and ME/CFS disrupt the body's natural energy production. At the core of this dysfunction is the mitochondrion, the organelle responsible for generating the vast majority of our cellular ATP. Recent research into Long COVID has revealed profound structural and functional abnormalities within the mitochondria. Viral persistence, chronic inflammation, and oxidative stress can damage the mitochondrial membranes and disrupt the electron transport chain, leading to a severe bottleneck in ATP production.

When the mitochondria cannot produce ATP efficiently through aerobic (oxygen-dependent) metabolism, the body is forced to rely on anaerobic glycolysis. This is a highly inefficient process that generates very little ATP and produces lactic acid as a byproduct. For a healthy person, this shift only occurs during intense, breathless exercise. For someone with ME/CFS or Long COVID, this shift can happen during minimal exertion, such as standing up or walking across the room. This premature reliance on anaerobic metabolism explains the rapid onset of muscle burning, heaviness, and the profound exhaustion that characterizes post-exertional malaise (PEM).

Furthermore, this mitochondrial impairment creates a vicious cycle of oxidative stress. Inefficient electron transport leads to the leakage of reactive oxygen species (ROS), which further damage the mitochondrial DNA and cellular structures. Studies have shown that Long COVID patients exhibit increased baseline oxygen consumption rates but poor ATP synthase activity, indicating a unique bioenergetic inefficiency. The cells are working harder but producing less usable energy, leaving the patient in a state of perpetual metabolic starvation.

The energy crisis of chronic illness is not limited to the muscles; it profoundly affects the brain. "Brain fog" is one of the most debilitating and universally reported symptoms of Long COVID and ME/CFS. This cognitive dysfunction is not merely psychological; it is rooted in neuroinflammation and microglial activation. Microglia are the resident immune cells of the central nervous system. When triggered by systemic inflammation or viral fragments, they shift into a hyperactive state, releasing inflammatory cytokines that disrupt normal neuronal signaling and impair the blood-brain barrier.

This neuroinflammatory state directly impacts the synthesis and utilization of critical neurotransmitters, particularly acetylcholine. Acetylcholine is essential for working memory, executive function, and the ability to sustain attention. When the brain is inflamed, the metabolic pathways required to synthesize acetylcholine from circulating choline are often compromised. This leads to a functional deficit in the cholinergic system, manifesting as forgetfulness, difficulty finding words, and an inability to concentrate on complex tasks.

Additionally, the brain is an incredibly energy-demanding organ, consuming roughly 20% of the body's total ATP despite accounting for only 2% of its mass. When systemic mitochondrial dysfunction lowers the availability of ATP, the brain simply does not have the fuel required to maintain high-level cognitive processing. This combination of neuroinflammation, neurotransmitter depletion, and local energy failure creates the dense, impenetrable cognitive fog that so many patients experience daily.

Another critical pathophysiological mechanism in Long COVID and dysautonomia is microvascular dysfunction. The endothelium, the inner lining of the blood vessels, plays a crucial role in regulating blood flow by releasing nitric oxide to dilate the vessels. In many post-viral conditions, the endothelium becomes inflamed and dysfunctional, a state known as endotheliitis. This impairs the vessels' ability to dilate appropriately in response to physical or cognitive demands, leading to localized tissue hypoxia (low oxygen).

This microvascular impairment is often compounded by the presence of fibrin amyloid microclots, which have been extensively documented in Long COVID patients. These microscopic clots can physically block the tiny capillaries that deliver oxygen and nutrients to the muscles and brain. Even if the lungs are taking in enough oxygen, and the heart is pumping adequately, the oxygen cannot successfully diffuse into the deep tissues.

The clinical result of this poor oxygen extraction is a drastically reduced VO2 max (the maximum rate of oxygen consumption during exercise). Patients often experience shortness of breath, tachycardia, and rapid muscle fatigue because their tissues are essentially suffocating at a cellular level. Addressing this oxygen utilization problem is paramount for improving exercise tolerance and reducing the severity of dysautonomic symptoms like those seen in Postural Orthostatic Tachycardia Syndrome (POTS).

When addressing the profound energy deficits of chronic illness, Thorne's Pre-Workout Elite deploys Peak ATP® to target microvascular dysfunction directly. While intracellular ATP is made by the mitochondria, orally supplemented ATP works in the extracellular space. When Peak ATP is ingested, it enters the bloodstream and acts as a powerful signaling molecule. It binds to specific purinergic receptors (P2Y2) located on the endothelial cells lining the blood vessels. This binding triggers a cascade that stimulates the synthesis and release of nitric oxide (NO) and endothelial-derived hyperpolarizing factor (EDHF).

The release of nitric oxide causes the smooth muscles around the blood vessels to relax, resulting in profound vasodilation. For a patient with Long COVID or ME/CFS struggling with endothelial dysfunction and microclots, this targeted vasodilation is critical. By widening the vascular pathways, Peak ATP helps bypass microcirculatory bottlenecks, dramatically improving the delivery of oxygen and glucose to oxygen-starved muscle tissues and the brain. Simultaneously, this increased blood flow helps flush out metabolic waste products like lactic acid and ammonia, which accumulate rapidly in patients who rely prematurely on anaerobic metabolism.

Furthermore, Peak ATP has been shown to increase muscular excitability. Muscle contraction relies on the release of calcium within the muscle fiber. Peak ATP helps sustain the extracellular calcium pool, allowing muscles to contract more efficiently with less neurological effort. In clinical trials, 400 mg of Peak ATP has been shown to significantly delay neuromuscular fatigue and maintain peak power output during repeated bouts of exertion, making it a powerful tool for extending a patient's functional capacity before reaching the threshold of exhaustion.

To combat the poor oxygen utilization seen in post-viral syndromes, the formula incorporates PeakO2®, a blend of six adaptogenic mushrooms. The primary driver in this blend is Cordyceps militaris, a fungus renowned for its ability to improve respiratory function and aerobic capacity. The active compounds in Cordyceps, including cordycepin and beta-glucans, work at the cellular level to enhance oxygen kinetics. They improve the efficiency with which cells extract oxygen from the blood and utilize it within the mitochondria to generate ATP.

Clinical studies on PeakO2 have demonstrated remarkable results in improving VO2 max and time to exhaustion. In a 21-day clinical trial, subjects taking PeakO2 experienced a significant increase in their VO2 max (up to 5.0 ml/kg/min) and extended their time to exhaustion by over 70 seconds compared to a placebo. For a chronic illness patient, improving VO2 max means that the body can sustain aerobic metabolism for longer periods before defaulting to the painful, inefficient anaerobic pathways that trigger PEM.

Beyond oxygen utilization, the adaptogenic nature of these mushrooms helps modulate the body's stress response. The blend contains powerful antioxidants like L-ergothioneine, which help neutralize the reactive oxygen species (ROS) generated by dysfunctional mitochondria. By reducing systemic oxidative stress and supporting efficient oxygen use, PeakO2 helps protect the cellular infrastructure from further damage, promoting a more resilient physiological baseline for daily activities.

To address the neurological component of fatigue and brain fog, Pre-Workout Elite utilizes Alpha-GPC. As a highly bioavailable choline donor, Alpha-GPC easily crosses the blood-brain barrier, where it is rapidly taken up by neurons. Once inside the brain, it serves as a direct precursor for the synthesis of acetylcholine. By flooding the central nervous system with this critical building block, Alpha-GPC helps overcome the metabolic bottlenecks caused by neuroinflammation, ensuring that the brain has an adequate supply of neurotransmitters to facilitate clear, focused thought.

The cognitive benefits of Alpha-GPC are well-documented in clinical literature. Studies involving patients with cognitive decline have shown that Alpha-GPC supplementation can significantly improve scores on cognitive assessments, enhancing memory recall, processing speed, and executive function. For a Long COVID patient experiencing word-finding difficulties or an inability to concentrate on a computer screen, supporting acetylcholine production can provide a noticeable lifting of the cognitive fog.

Moreover, acetylcholine is not just a brain chemical; it is the primary neurotransmitter at the neuromuscular junction. It is responsible for translating the brain's intention to move into an actual muscle contraction. By optimizing acetylcholine levels, Alpha-GPC enhances brain-to-muscle signaling. This means that movements require less perceived neurological effort, reducing the central nervous system fatigue that often accompanies physical exertion in ME/CFS patients.

The inclusion of Guayusa extract provides a fascinating solution to the stimulant dilemma faced by many chronic illness patients. Patients with dysautonomia or POTS are often highly sensitive to caffeine, as it can trigger tachycardia and exacerbate sympathetic nervous system overdrive. However, Guayusa offers a unique pharmacological profile. While it contains naturally occurring caffeine, it is also densely packed with chlorogenic acids and the amino acid L-theanine.

This phytochemical matrix fundamentally alters how the body processes the stimulant. In a landmark 2016 clinical trial, researchers found that while Guayusa and synthetic caffeine raised blood caffeine levels equally, Guayusa stimulated a significantly lower increase in epinephrine (adrenaline). The synthetic caffeine caused a massive spike in stress hormones, whereas the Guayusa extract blunted this response by nearly 80%. This means the central nervous system remains calmly stimulated without being pushed into a "fight or flight" panic state.

For patients, this translates to sustained mental alertness and physical energy without the jitteriness, heart palpitations, or severe post-stimulant crashes associated with standard energy drinks. The L-theanine promotes alpha brain wave activity, fostering a state of relaxed focus, while the chlorogenic acids slow the absorption of caffeine in the gut, providing a smooth, extended release. This allows patients to benefit from improved alertness without destabilizing their fragile autonomic nervous systems.

While Thorne Pre-Workout Elite is marketed for athletic performance, its mechanisms of action directly target the cellular deficits underlying many chronic illness symptoms. By supporting mitochondrial output, oxygen delivery, and neurotransmitter synthesis, this formula may help manage the following specific challenges:

It is important to note that while these ingredients provide powerful biochemical support, they are not a cure for the underlying disease processes. They serve as a supportive tool to help optimize the body's available resources, making daily tasks more manageable and potentially improving overall quality of life when used as part of a comprehensive management strategy.

When introducing a supplement designed to enhance energy production, the most critical consideration for patients with Long COVID or ME/CFS is pacing. It is incredibly easy to fall into the "push-and-crash" cycle. If you take Pre-Workout Elite and suddenly feel a surge of physical and cognitive clarity, the immediate temptation is to tackle the mountain of chores or work tasks you have been putting off. However, ignoring your energy envelope and pushing past your baseline will inevitably trigger post-exertional malaise (PEM), regardless of what supplements you are taking.

The goal of using these cellular fuels is not to artificially inflate your energy envelope so you can do more; the goal is to make the activities you are already doing less physiologically costly. If your daily baseline allows for 15 minutes of light stretching and an hour of computer work, use the supplement to make those specific tasks feel easier and to recover from them faster. Over time, as your cellular efficiency improves and your baseline stabilizes, you can slowly and carefully expand your activity levels under the guidance of a healthcare provider.

Always listen to your body. If you notice that you are consistently crashing the day after taking the supplement, it is a clear sign that you are using the increased energy to overexert yourself. Symptom tracking is essential here. Keep a daily log of your supplement intake, activity levels, and symptom severity to identify patterns and ensure you are staying within your safe functional limits.

Thorne Pre-Workout Elite comes in a powder form with a citrus berry flavor, designed for easy mixing. The suggested use is one scoop mixed with at least 10 ounces of water or your preferred beverage. Because the active ingredients—particularly Peak ATP and Alpha-GPC—are rapidly absorbed and utilized by the body, timing is important. For optimal results, it should be consumed 15 to 30 minutes before your planned activity. This allows the extracellular ATP to bind to vascular receptors and the Alpha-GPC to peak in the bloodstream right as you begin your physical or cognitive exertion.

If you are using this supplement primarily for cognitive support (e.g., before a long meeting or a period of intense focus), taking it 30 minutes prior will ensure that acetylcholine synthesis is upregulated when you need it most. Because the formula contains adaptogenic mushrooms that benefit from systemic saturation, some patients find that consistent daily use yields better long-term improvements in baseline energy and oxygen utilization compared to sporadic, as-needed dosing.

When starting any new supplement, especially one with complex active ingredients, it is wise to start low and go slow. Consider beginning with a quarter or half scoop to assess your body's tolerance and biochemical response. This is particularly important for patients with sensitive gastrointestinal tracts or those prone to MCAS flares, as the introduction of new botanical extracts can sometimes trigger localized reactions.

While the Guayusa extract in this formula is specifically chosen for its ability to blunt the adrenaline response, it still contains naturally occurring caffeine. One full scoop of Pre-Workout Elite provides approximately the same amount of caffeine as a standard cup of coffee. For the general population, this is a moderate and well-tolerated dose. However, for patients with severe dysautonomia or POTS, any central nervous system stimulant can potentially exacerbate tachycardia or trigger autonomic instability.

If you are highly sensitive to caffeine, you must approach this supplement with caution. The L-theanine and chlorogenic acids in Guayusa do an excellent job of smoothing out the energy curve and preventing jitters, but they do not negate the presence of the stimulant entirely. Patients with a known history of severe hypersensitivity to caffeine or any of the botanical ingredients (such as mango extract or specific mushroom strains) should consult their healthcare provider before use.

Additionally, because Alpha-GPC increases acetylcholine levels, some individuals with naturally high baseline choline may experience a paradoxical effect, feeling mild brain fog or lethargy. If you experience headaches or increased cognitive heaviness after taking the supplement, it may indicate that your cholinergic system is overstimulated, and you should reduce the dosage or discontinue use.

The ingredients in Thorne's Pre-Workout Elite are supported by a robust body of clinical research, much of which focuses on their ability to enhance cellular efficiency and delay fatigue. A landmark 12-week, double-blind, placebo-controlled trial published in the Journal of the International Society of Sports Nutrition (Jäger et al., 2014) investigated the effects of 400 mg of daily Peak ATP®. The researchers used ultrasonography to measure blood flow and found that ATP supplementation significantly elevated both volumetric blood flow and blood vessel dilation, increasing blood flow to working muscles by up to 54%. This profound vasodilation is a key mechanism for clearing metabolic waste and delivering oxygen.

Further research published in the Journal of the American College of Nutrition (Purpura et al., 2017) focused on muscular excitability and fatigue. In this study, subjects taking 400 mg of Peak ATP maintained peak power output and experienced almost no decline in muscle excitability during repeated high-intensity sprints, whereas the placebo group saw a 30% decline. This demonstrates ATP's ability to prevent the exercise-induced depletion of internal energy stores.

The PeakO2® mushroom blend is equally well-researched. A study conducted at the University of North Carolina, Chapel Hill (Hirsch et al., 2017) tested the effects of the adaptogenic blend on aerobic capacity. After 21 days of supplementation, the PeakO2 group saw their VO2 max increase by roughly 4.0 to 5.0 ml/kg/min, and their time to exhaustion improved by a massive 70 seconds compared to the placebo group. This highlights the blend's powerful impact on oxygen utilization and endurance.

The cognitive benefits of Alpha-GPC have been extensively studied, particularly in populations experiencing cognitive decline or neuroinflammation. A major clinical trial known as the ASCOMALVA study evaluated patients with Alzheimer's disease and cerebrovascular injury. The trial found that combining standard medication with Alpha-GPC significantly delayed the progression of cognitive decline and reduced symptoms of apathy and depression compared to medication alone, underscoring its neuroprotective properties.

In a more recent 2023 meta-analysis published in Pharmacological Research, researchers confirmed that Alpha-GPC significantly improved cognitive assessment scores (such as the Mini-Mental State Examination) in patients with adult-onset cognitive dysfunction. The compound's ability to efficiently cross the blood-brain barrier and upregulate acetylcholine synthesis makes it a highly effective intervention for neuroinflammatory-driven brain fog.

Research also supports Alpha-GPC's role in healthy populations facing extreme cognitive demands. A 2024 double-blind study utilizing the Stroop Test—a gold-standard metric for processing speed and selective attention—found that Alpha-GPC supplementation significantly improved reaction times and cognitive precision under pressure, demonstrating its efficacy as a powerful nootropic agent.

The unique "jitter-free" energy provided by Guayusa extract is validated by pharmacokinetic research. A pivotal double-blind crossover clinical trial (Krieger et al., 2016) compared the physiological responses of Guayusa extract, green coffee extract, and synthetic caffeine. While all three sources raised blood plasma caffeine levels equally, the neuroendocrine responses were drastically different.

The study revealed that synthetic caffeine increased epinephrine (adrenaline) levels by +2.78 μg/gCr, triggering a strong sympathetic nervous system response. In stark contrast, the Guayusa extract only increased epinephrine by +0.5 μg/gCr—an approximately 80% reduction in the stress-hormone response. This data scientifically validates the mechanism by which Guayusa's chlorogenic acids and L-theanine buffer the central nervous system, providing sustained energy without the autonomic panic.

Additional research published in Nutrients (2021) evaluated the dose-response effects of Guayusa on mood and cognitive performance. Participants taking Guayusa extract reported significantly greater perceived energy and heightened focus without the corresponding increases in tension, anxiety, or heart rhythm abnormalities commonly seen with standard caffeine doses, reinforcing its safety profile for sensitive individuals.

Living with a complex chronic condition like Long COVID, ME/CFS, or dysautonomia often feels like navigating a daily labyrinth with a failing flashlight. The profound fatigue, unpredictable cognitive fog, and the constant threat of post-exertional crashes can strip away your sense of autonomy. It is completely valid to feel frustrated by a medical system that often lacks targeted solutions for these deep, cellular-level energy deficits. Acknowledging the physiological reality of your symptoms—that your mitochondria are struggling and your neurochemistry is inflamed—is the first step toward reclaiming control.

Thorne's Pre-Workout Elite represents a sophisticated approach to supporting these exact physiological vulnerabilities. By providing direct cellular fuels like Peak ATP® and Alpha-GPC, alongside the adaptogenic power of PeakO2® and Guayusa, this formula offers a way to support blood flow, oxygen utilization, and neurotransmitter synthesis. It is not about pushing your body to run a marathon; it is about giving your cells the raw materials they need to make reading a book, preparing a meal, or enjoying a conversation feel less biologically expensive.

While the science behind these ingredients is compelling, supplements are only one piece of a comprehensive management puzzle. They must be integrated into a broader strategy that includes strict pacing, symptom tracking, nervous system regulation, and potentially prescription therapeutics. Cellular fuels can help optimize your available energy, but they cannot replace the foundational need for rest and medical supervision.

Always consult with your healthcare provider before introducing a new supplement, especially if you are managing severe dysautonomia, MCAS, or are taking prescription medications. Your provider can help you determine the appropriate dosage and ensure that the ingredients align with your specific clinical presentation and treatment goals.